As is the case with most professions, females make between 10 and 30 percent less than their male counterparts for doing the same job. After crunching some numbers, pharmaceutical giant Merck saw a huge opportunity.
“We can hire women scientists with the exact same credentials as men, but pay them much less” said Merck CFO Ron Duttlit. “It’s going to save us a huge sum of money which we can then plug into our marketing and shill programs.”
Merck’s total sales in 2014 were a measly $42.2 billion, a huge disappointment. Over 90% of that revenue comes either directly from vaccines or the diseases and conditions that vaccines cause.
“We need to keep up the vaccine and vaccine related revenue, which means saving money in the lab and paying more shills and trolls to comment on the internet” said Duttlit. “I would say at least 95% of people who are pro-vaccine on the internet are receiving money from either Big Pharma or Monsanto, and that can get expensive.”
